Switch, Inc. Securities Litigation

According to the Complaint, this is a federal securities action on behalf of a class consisting of all persons who
purchased or otherwise acquired Switch Class A common stock pursuant to and/or traceable to the Company's initial public offering commenced on or around October 6, 2017 (the "IPO" or the "Offering") seeking to recover damages caused by Defendants' violations of Sections 11, 12 and 15 of the Securities Act of 1933 ("Securities Act").

See Case Details »

REV Group, Inc. Securities Litigation

Plaintiff's law firm issued a press release on June 8, 2018, announcing the lawsuit on behalf of purchasers of REV Group, Inc. (NYSE:REVG) securities pursuant and/or traceable to REV Group's initial public offering ("IPO") on or about January 27, 2017. The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) REV Group was unable to use its "strong visibility into future net sales" to "effectively plan" and manage its backlog of vehicles; (2) REV Group facilities were not operating efficiently or at a low cost to satisfy customer demand; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

See Case Details »

Qualcomm Incorporated Securities Litigation (2018)

Plaintiff's law firm issued a press release on June 8, 2018, announcing the lawsuit. According to the press release, QUALCOMM develops and commercializes "foundational technologies and products used in mobile devices and other wireless products." The Company derives revenues principally from the sale of integrated circuit products and the licensing of intellectual property. Broadcom Limited ("Broadcom") is a "designer, developer and global supplier of a broad range of semiconductor devices, with a focus on complex digital and mixed signal complementary metal oxide semiconductor ["CMOS"] based devices and analog III-V based products." Broadcom is incorporated in, and maintains its principal executive offices in, Singapore.

See Case Details »

Esperion Therapeutics, Inc. Securities Litigation (2018)

On May 7, 2018, Plaintiff's law firm issued a press release announcing the lawsuit. According to the press release, Esperion is a biopharmaceutical company that is primarily focused on the research and development of oral and small molecule therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol and other cardio metabolic risk factors. Bempedoic acid and its lead product candidate, the bempedoic acid / ezetimibe combination pill, are targeted therapies focused on reducing elevated LDL-C levels in patients with hypercholesterolemia. The Company owns the exclude worldwide rights to bempedoic acid.

See Case Details »

Infinity Property and Casualty Corp. Securities Litigation

According to the Complaint, Infinity Property and Casualty Corp. ("Infinity") was incorporated in 2002 and it is a holding company that provides insurance, through its subsidiaries, for personal auto with a concentration on non-standard risks, commercial auto and classic collectors.

See Case Details »